¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Nerve conduction study"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® vagus nerve ÇÑ±Û ¹ÌÁֽŰæ
¼³¸í   
  Á¦ 10³ú½Å°æ(³ú½Å°æÀº ³ú¿¡¼­ ±â½ÃÇÑ ¸»ÃʽŰæÀ¸·Î ¸ðµÎ 12°³°¡ ÀÖ´Ù)ÀÇ À̸§. ¿Ã¸®ºê¿Í ¾Æ·¡¼Ò³ú°¢(inferior cerebellopontine angle)»çÀÌ ¼û³ú ¿ÜÃø¿¡¼­ ³ª¿À´Â ¸¹Àº »Ñ¸®¼¶À¯·ÎºÎÅÍ ±â½ÃÇÏ¿© »óÈĵνŰæ, µÇµ¹ÀÌÈĵνŰæ, °æÁú¸·°¡Áö, ±Í¹ÙÄû°¡Áö, Àεΰ¡Áö, ½ÉÀå°¡Áö, ±â°üÁöÀÎÁö, À§°¡Áö, °£°¡Áö, º¹°­°¡Áö, ÄáÆÏ°¡Áö, ÀενŰæ¾ó±â(pharyngeal plexus), Æó½Å°æ¾ó±â(pulmonic plexus), ½Äµµ½Å°æ¾ó±â(esophageal plexus), Àü ¹× ÈÄ ¹ÌÁֽŰ氣(anterior & posterior vagal trunk)ÀÇ °¡Áö¸¦ ³½´Ù. ¹ÌÁֽŰæÀº ¸ñÁ¤¸Æ±¸¸Û(jugular foramen)À» ÅëÇØ ³»·Á°¡¼­ »óÇϽŰæÀý(superior & inferior ganglion)°ú ¿¬°áµÇ°í, ¸ñ ¹× °¡½¿¸¦ Áö³ª º¹ºÎ¿¡ µµ´ÞÇÑ´Ù. ±Í, Çô, ÀεÎ, Èĵο¡ °¨°¢¼ºÀ¸·Î, ÀεÎ, ÈĵΠ¹× ½Äµµ¿¡ ¿îµ¿¼ºÀ¸·Î, ±×¸®°í ÈäºÎ ¹× º¹ºÎÀÇ ±â°ü¿¡ ³»À屸½É¼ºÀ¸·Î ºÐÆ÷ÇÑ´Ù.
  
  ¹ÌÁֽŰæ
  
  
¿µ¹® optic nerve ÇÑ±Û ½Ã°¢½Å°æ
¼³¸í   
  ½Ã°¢À» ÀÎÁöÇϴ ½Å°æ. ÀÌ ½Å°æÀº ´ÜÁö °¨°¢½Å°æÀ¸·Î¼­¸¸ ÀÛ¿ëÇÑ´Ù. µû¶ó¼­ ¾î¶² »ç¹°À» µû¶ó ´«À» ¿òÁ÷ÀÏ ¼ö Àִ °ÍÀº ÀÌ ½Ã°¢½Å°æ°ú´Â ¹«°üÇÏ´Ù(À̰ÍÀº ´«µ¹¸²½Å°æ(oculomotor nerve)¿¡ ÀÇÇØ °¡´ÉÇÏ´Ù). ¶ÇÇÑ ½Ã°¢½Å°æÀº °íÀ§ÁßÃ߽Űæ°èÀΠ³ú¿¡¼­ Á÷Á¢ ºÐÁöÇϹǷΠ¼Õ»ó½Ã Àç»ýÀº ºÒ°¡´ÉÇϸç, ÀÌ¿¡ ´ëÇÑ Ä¡·á¹ýÀº ¾ø´Ù.
¿µ¹® nerve ÇÑ±Û ½Å°æ
¼³¸í   
  »ý¹°ÀÌ ÀÚ½ÅÀÇ ¸ö°ú ÁÖÀ§¿¡¼­ ÀϾ´Â °¢Á¾ º¯È­¸¦ °¨ÁöÇϰí Á¾ÇÕÇÏ¿© ÀûÀýÇÑ ¹ÝÀÀÀ» ÀÏÀ¸Å°µµ·Ï Çϴ ±â°ü. ¼ö¸¹Àº ½Å°æ ¼¼Æ÷·Î µÇ¾î ÀÖ´Ù. À°¾È»ó ²ö ¸ð¾çÀÇ ±¸Á¶·Î¼­, ÁßÃ߽Űæ°è¿Í ½ÅüÀÇ °¢ ºÎºÐ »çÀÌ¿¡¼­ ½Å°æÃ浿À» Àü´ÞÇϴ ½Å°æ¼¶À¯ÀÇ ÁýÇÕÀÌ´Ù. ½Å°æÀº ½Å°æ¼¶À¯ÀÇ ´Ù¹ßÀ» µÑ·¯½Î´Â °áÇÕÁ¶Á÷¼ºÀÇ Áý(sheath)À¸·Î ÀÌ·ç¾îÁø´Ù. °¢ ½Å°æ¼¶À¯¼ÓÀº ½Å°æ´Ù¹ß¸·(perineurium)À̶ó ºÎ¸£´Â °áÇÕÁ¶Á÷¼ºÀÇ °íÀ¯ÀÇ ÁýÀ¸·Î µÑ·¯½Î¿© ÀÖÀ¸¸ç, ¸·ÀÇ ³»¸éÀº ÆíÆòÇÑ ÁßÇǼ¼Æ÷ÀÇ ¸·À¸·Î µÇ¾î ÀÖ´Ù. ¸Å¿ì ÀÛÀº ½Å°æÀº ¸ð½Å°æ¿¡¼­ ³ª¿Â ´Ü ÇѰ³ÀÇ ½Å°æ»èÀ¸·Î ÀÌ·ç¾îÁö±âµµ ÇÑ´Ù. ÀÌ·¯ÇÑ ½Å°æ¼Ó³»¿¡¼­, Çö¹Ì°æÀ¸·Î °üÂûµÉ ¼ö Àִ °¢ ½Å°æ¼¶À¯´Â °£Áú¼º °áÇÕÁ¶Á÷ÀΠ½Å°æ¼¶À¯¸·(endoneurium)À¸·Î µÑ·¯½Î¿© ÀÖ´Ù. °¢ ½Å°æ¼¶À¯(Ãà»è°ú À̸¦ ½Î°í Àִ Áý)´Â ¿øÇüÁú·Î µÈ ±âÁúÀΠÃà»èÇüÁú(axoplasm)°ú À̰ͳ»ÀÇ À¯Çü¼ººÐÀ¸·Î ±¸¼ºµÇ¾î ÀÖ°í, Àüü±¸Á¶´Â ¾ãÀº Ãà»èÁý(axolemma)À¸·Î µÑ·¯½Î¿© ÀÖÀ¸¸ç, ½Å°æÁý¼¼Æ÷¿¡ À¯·¡ÇÑ ÁöÁúÃþÀΠ¸»ÀÌÁý(myelin sheath)ÀÌ Àִ °Íµµ ÀÖ°í, ¾ø´Â °Íµµ ÀÖ´Ù.
  
  ½Å°æ
¿µ¹® nerve ÇÑ±Û ½Å°æ
¼³¸í   
  ¿©·¯ ±â°üµéÀÇ ¼­·Î°£ »óÈ£¿¬°áü°è°¡ ¹Ù·Î ½Å°æ°èÀÌ´Ù. ÀÌ·¯ÇÑ ½Å°æ°è´Â °¢ ½Å°æ¼¼Æ÷µé¿¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖÀ¸¸ç, ¿©±â¿¡´Â ÁßÃ߽Űæ°è(central nerve system: CNS)¿Í ¸»ÃʽŰæ°è(peripheral nerve system: PNS)°¡ ÀÖ´Ù. ÁßÃ߽Űæ°è¶õ ³ú¿Í Ã´¼ö¸¦ ¸»Çϸç, ¸»ÃʽŰæ°è´Â 12½ÖÀÇ ³ú½Å°æ(cranial nerve: ³ú¿¡¼­ ±â½ÃÇÏ¿© ÁַΠ¾ó±¼ºÎÀ§¿Í ¸ñ ºÎÀ§¿¡ ºÐÆ÷ÇÑ´Ù)°ú 31½ÖÀǠô¼ö½Å°æ(spinal nerve: spinal cord¿¡¼­ °¢±â ¾çÂÊÀ¸·Î ½ÖÀ» ÀÌ·ç¾î ³ª¿À´Âµ¥ ÁַΠ¸ñÀÌÇϺÎÀ§ÀÇ ½Åü °¢ ºÎºÐÀ¸·Î ºÐÆ÷ÇϰԠµÈ´Ù)À¸·Î ±¸¼ºµÇ¾î ÀÖ´Ù. ¶ÇÇÑ ¸»ÃʽŰæ°è¿¡´Â ¾Õ¿¡¼­ ¸»ÇÑ ³ú½Å°æ°ú Ã´¼ö½Å°æ¿Ü¿¡ ÀÚÀ²½Å°æ°è°¡ Á¸ÀçÇÑ´Ù. ÀÚÀ²½Å°æ°è´Â ´Ù½Ã ±³°¨½Å°æ°ú ºÎ±³°¨½Å°æÀ¸·Î ³ª´µ¾îÁ® ¼­·Î°£ÀÇ ¿Ã¹Ù¸¥ »óÈ£ÀÛ¿ëÀ¸·Î ¸ö¼Ó¿¡¼­ ¿©·¯ °¡Áö ÀÛ¿ëÀ» ¼öÇàÇÑ´Ù.
¿µ¹® nerve cell ÇÑ±Û ½Å°æ¼¼Æ÷
¼³¸í   
  ½Å°æ¼¼Æ÷´Â ¿Ã¹Ù¸¥ ½Å°æÀü´ÞÀ» À§ÇÑ °¢ ºÎºÐº°·Î ³ª´µ¾îÁ® ÀÖ´Ù. ½Å°æ¼¼Æ÷¿¡¼­´Â ÀüÇØÁ®¿À´Â ÀÚ±ØÀ» Àü±âÀûÀΠ½ÅÈ£·Î ¹Ù²î¾î º¸³»°Å³ª ¹Þ°Ô µÈ´Ù. ÀÌ·± Àü±âÀûÀΠÇö»óÀº °¢ ½Å°æ¼¼Æ÷³»¿¡ Á¸ÀçÇϴ °¢ ÀÌ¿Âä³Î(ion channel: ionÀ̶õ ³ªÆ®·ý, Ä®·ý µîÀ» ÁöĪÇϴ ¸»µé·Î½á, À̵éÀÌ ¼¼Æ÷¸·¿¡ ÀÇÇØ ³ª´µ¾îÁú ¶§ »ý±â´Â Àü¾ÐÂ÷°¡ Àü±âÀû ÀÚ±ØÀ» ÀÏÀ¸Å°°í À¯ÁöÇϴµ¥ °áÁ¤ÀûÀΠ¿ªÇÒÀ» ÇÑ´Ù)µéÀÇ ÀÛ¿ë¿¡ ÀÇÇØ ÀÌ·ç¾îÁö°Ô µÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • follow-up study
    ÃßÀûÁ¶»ç
  • family study
    °¡Á·Á¶»ç
  • longitudinal study
    ÃßÀû¿¬±¸
  • molecular genetic study
    ºÐÀÚÀ¯ÀüÇа˻ç
  • neurophysiological study
    ½Å°æ»ý¸®ÇÐÀû°Ë»ç
  • observational study
    °üÂû¿¬±¸
  • pilot study
    ¿¹ºñ¿¬±¸
  • population study
    Àα¸Á¶»ç
  • preclinical study
    ÀÓ»óÀü½ÃÇè, ÀüÀӻ󿬱¸
  • pressure flow study
    ¾Ð·Â¿ä·ù°Ë»ç
  • prospective cohort study
    ÀüÇâÄÚȣƮ¿¬±¸
  • prospective study
    ÀüÇ⿬±¸, °èȹ¿¬±¸
  • real time study
    ½Ç½Ã°£°Ë»ç
  • retrospective cohort study
    ÈÄÇâÄÚȣƮ¿¬±¸
  • retrospective study
    ÈÄÇ⿬±¸
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ecological study
    »ýÅ¿¬±¸
  • longitudinal study
    ÃßÀû¿¬±¸
  • observational study
    °üÂû¿¬±¸
  • pilot study
    ¿¹ºñ¿¬±¸
  • population study
    Àα¸Á¶»ç
  • prospective study
    ÀüÇ⿬±¸, °èȹ¿¬±¸, ¾Õ¹æÇ⿬±¸, Àü¸Á¿¬±¸
  • prospective cohort study
    ÀüÇâÄÚȣƮ¿¬±¸
  • retrospective study
    ÈÄÇ⿬±¸, µÞ¹æÇ⿬±¸, ȸ°í¿¬±¸
  • retrospective cohort study
    ÈÄÇâÄÚȣƮ¿¬±¸
  • single blinding study
    ´Ü¼ø¸Í°Ë¹ý
  • urodynamic study
    ¿ä¿ªµ¿Çа˻ç
  • optic nerve atrophy
    (¢¡optic atrophy) ½Ã°¢½Å°æÀ§Ãà
  • intercostal nerve block
    °¥ºñ»çÀ̽ŰæÂ÷´Ü, ´Á°ñ°£½Å°æÂ÷´Ü
  • nerve compression
    ½Å°æ¾Ð¹Ú
  • afferent nerve fiber
    µé½Å°æ¼¶À¯
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cross-sectional study
    ´Ü¸éÁ¶»ç¿¬±¸
  • double-blind study
    ÀÌÁ߸Ͱ˹ý
  • study design
    ¿¬±¸°èȹ
  • family study
    °¡Á·Á¶»ç
  • feasibility study
    °¡´É¼º¿¬±¸
  • first pass study
    ÀÏÂ÷Åë°ú°Ë»ç
  • follow-up study
    ÃßÀûÁ¶»ç
  • infection control study
    °¨¿°°ü¸®Á¶»ç
  • intervening study
    °³ÀÔ¿¬±¸
  • longitudinal study
    ÃßÀû¿¬±¸
  • microbiologic study
    ¹Ì»ý¹°Çа˻ç
  • migrant study
    ÀÌÁֹבּ¸
  • mixing study
    È¥ÇÕ°Ë»ç
  • molecular genetic study
    ºÐÀÚÀ¯ÀüÇа˻ç
  • neurophysiological study
    ½Å°æ»ý¸®ÇÐÀû°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Conduction aphagia
    Àüµµ¼º ¿¬ÇϺҴÉÁõ
  • Conduction deafness
    Àüµµ¼º(îîÓôàõ)³­Ã»(Ññôé)
  • Conduction time
    Àüµµ½Ã°£
  • aberrant conduction
    ÀÌ»óÀüµµ(ì¶ßÈîîÓô).
  • abnormality of conduction
    ÀüµµÀÌ»ó.
  • aerial conduction
    °ø±âÀüµµ(Ë­Ë»ËøËÄ).
  • anomalous conduction
    ÀÌ»óÀüµµ.
  • antegrade conduction
    Àü¹æÇâÀüµµ
  • antidromic conduction
    ¿ªÇ༺ Àüµµ(æ½ú¼àõîîÓô)
  • aphasia, conduction
    Àüµµ¼º ½Ç¾îÁõ
  • hearing, air conduction
    ±âµµÃ»·Â
  • hearing, bone conduction
    °ñµµÃ»·Â
  • heat conduction
    ¿­Àüµµ(æðîîÓô).
  • impulse conduction
    ÈïºÐÆÄÀüµµ(ýéÝÇ÷îîîÓô).
  • impulse conduction system
    ÈïºÐÆÄÀüµµ°è.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • molecular genetic study
    ºÐÀÚÀ¯ÀüÇÐ<ÀÚ>°Ë»ç
  • nested case control study
  • phase 1 study
    ÀÓ»óÁ¦1»ó½ÃÇè.
  • pilot study
    ¿¹ºñ½ÇÇè.
  • population study
    Àα¸Á¶»ç
  • preclinical study
    ÀüÀÓ»ó½ÃÇè(îñìúßÉãËúÐ).
  • pressure flow study
    ¾Ð·ù·® Á¶»ç
  • pressure-perfusion study
    ¾Ð·Â°ü·ù°Ë»ç
  • prospective study
    °èȹÀû¿¬±¸, ÀüÇâÀû¿¬±¸
  • real time study
    ½Ç½Ã°£ °Ë»ç
  • retrospective study
    ÈÄÇâÀû¿¬±¸
  • single blind study
    ´ÜÀÏ<¼ø>¸Í°Ë¹ý.
  • time study
    ½Ã°£¿¬±¸(¡­æÚϼ).
  • tracer study
    ÃßÀûÀÚ¿¬±¸(õÚîæíºæÚϼ).
  • twin study
    ½Ö»ý¾Æ¿¬±¸(¡­æÚϼ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Abducent nerve (VI)
    °«µ¹¸²½Å°æ
    [¿¾ ¿ë¾î] ¿ÜÀü½Å°æ
  • Axillary nerve
    °Üµå¶û½Å°æ
    [¿¾ ¿ë¾î] ¾×¿Í½Å°æ
  • Nerve to tensor tympani
    °í¸·±äÀå±Ù½Å°æ
    [¿¾ ¿ë¾î] °í¸·Àå±Ù½Å°æ
  • Chorda tympani nerve
    °í½Ç²ö½Å°æ
    [¿¾ ¿ë¾î] °í»è½Å°æ
  • Tympanic nerve
    °í½Ç½Å°æ
    [¿¾ ¿ë¾î] °í½Ç½Å°æ
  • Perforating cutaneous nerve
    °üÅëÇǺνŰæ
    [¿¾ ¿ë¾î] °üÅëÇǽŰæ
  • Zygomatic nerve
    ±¤´ë½Å°æ
    [¿¾ ¿ë¾î] °ü°ñ½Å°æ
  • Communicating branches (with chorda tympani nerve)
    ±³Åë°¡Áö(°í½Ç²ö½Å°æ°úÀÇ)
    [¿¾ ¿ë¾î] ±³ÅëÁö(°í»è½Å°æ°úÀÇ)
  • Communicating branch (with zygomatic nerve)
    ±³Åë°¡Áö(±¤´ë½Å°æ°úÀÇ)
    [¿¾ ¿ë¾î] ±³ÅëÁö
  • Communicating branch (with auriculotemporal nerve)
    ±³Åë°¡Áö(±Ó¹ÙÄû°üÀڽŰæ°úÀÇ)
    [¿¾ ¿ë¾î] ±³ÅëÁö(À̰³ÃøµÎ½Å°æ°úÀÇ)
  • Communicating branch (with recurrent laryngeal nerve)
    ±³Åë°¡Áö(µÇµ¹ÀÌÈĵνŰæ°úÀÇ)
    [¿¾ ¿ë¾î] ±³ÅëÁö(¹Ýȸ½Å°æ°úÀÇ)
  • Communicating branch (with vagus nerve)
    ±³Åë°¡Áö(¹ÌÁֽŰæ°úÀÇ)
    [¿¾ ¿ë¾î] ±³ÅëÁö(¹ÌÁֽŰæ°úÀÇ)
  • Communicating branch (with auricular branch of vagus nerve)
    ±³Åë°¡Áö(¹ÌÁֽŰæ±Ó¹ÙÄû°¡Áö¿ÍÀÇ)
    [¿¾ ¿ë¾î] ±³ÅëÁö(¹ÌÁֽŰæÀ̰³Áö¿ÍÀÇ)
  • Communicating branch (with medial pterygoid nerve)
    ±³Åë°¡Áö(¾ÈÂʳ¯°³±Ù½Å°æ°úÀÇ)
    [¿¾ ¿ë¾î] ±³ÅëÁö(³»ÃøÀ͵¹±Ù½Å°æ°úÀÇ)
  • Communicating branches (with facial nerve)
    ±³Åë°¡Áö(¾ó±¼½Å°æ°úÀÇ)
    [¿¾ ¿ë¾î] ±³ÅëÁö(¾È¸é½Å°æ°úÀÇ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • glossopharyngeal nerve
    ¼³ÀνŰæ
  • iliohypogastric nerve
    Àå°ñÇϺ¹½Å°æ
  • inferior laryngeal nerve
    ¾Æ·¡ÈĵνŰæ, ÇÏÈĵνŰæ
  • intercostal nerve
    ´Á°£½Å°æ
  • intermediate nerve
    Áß°£½Å°æ
  • jugular nerve
    °æÁ¤¸Æ½Å°æ
  • lacrimal nerve
    ´©¼±½Å°æ
  • laryngeal nerve
    ÈĵνŰæ
  • lingual nerve
    ¼³½Å°æ
  • lower cranial nerve nuclei
    ÇϺγú½Å°æÇÙ
  • mandibular nerve
    ÇϾǽŰæ
  • maxillary nerve
    »ó¾Ç½Å°æ
  • median nerve
    Á¤Á߽Űæ
  • motor nerve
    ¿îµ¿½Å°æ
  • multiple cranial nerve palsy
    ´Ù¹ß¼º³ú½Å°æ¸¶ºñ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EMG/NCV electromyography/nerve conduction velocity [test]
MNCV motor nerve conduction velocity
NCV nerve conduction velocity; noncholera vibrio
SCV sensory nerve conduction velocity; smooth, capsulated, virulent; subclavian vein; squamous-cell carc...
SNCS sensory nerve conduction studies
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NCV Nerve conduction velocities
NCVs Nerve conduction velocities
SNCV Sensory Nerve Conduction Velocity
DCV distribution of nerve conduction velocities
SCV sensory nerve conduction velocity
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • saltatory conduction
    µµ¾à Àüµµ
    ¼öÃÊ ºÎºÐÀ» ³Ñ¾î ±³·ûºÎ¸¸ ÀüµµµÇ´Â °Í.
  • somatosensory conduction pathway
    ü°¨°¢ Àüµµ °æ·Î
  • synaptic conduction
    ½Ã³³½º Àüµµ, ¿¬Á¢ Àüµµ
  • unidirectional conduction
    ÀÏ ¹æÇ⼺ Àüµµ
  • air study
    °ø±â °Ë»ç, °ø±â ÁÖÀÔ °Ë»ç, °ø±â °Ë»ç¹ý, °ø±â ÁÖÀÔ °Ë»ç¹ý
  • arterial blood gas study
    µ¿¸ÆÇ÷ °³½º ºÐ¾Ð ÃøÁ¤
  • case control study
    ȯÀÚ ´ëÁ¶ ¿¬±¸
  • case study
    Áõ·Ê ¿¬±¸
  • coagulation study
    ÀÀ°í °Ë»ç
  • controlled clinical study
    °ü¸®È­ ½ÃÇè, °ü¸®È­ ÀÓ»ó ½ÃÇè, Ãß°èÇÐÀû °ü¸®È­ ½ÃÇè, Ãß°èÇÐÀû °ü¸®È­ ÀÓ»ó ½ÃÇè
  • cross-sectional study
    Ⱦ´Ü ¿¬±¸¹ý, Ⱦ´Ü Á¶»ç¹ý
  • double-blind study
    ÀÌÁß ¸Í°Ë ¿¬±¸
  • electroencephalographic study
    ³úÆÄ °Ë»ç
  • enzyme marker study
    È¿¼Ò Ç¥Áö ¿¬±¸
  • longitudinal study
    ´©³âÀû ¿¬±¸, Á¾Àû ¿¬±¸, Á¾´Ü ¿¬±¸¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
prospective study <epidemiology> A study in which people are initially enrolled and then followed up at subsequent times.
(05 Dec 1998)
study 1. To apply the mind to; to read and examine for the purpose of learning and understanding; as, to study law or theology; to study languages.
2. To consider attentively; to examine closely; as, to study the work of nature. "Study thyself; what rank or what degree The wise Creator has ordained for thee." (Dryden)
3. To form or arrange by previous thought; to con over, as in committing to memory; as, to study a speech.
4. To make an object of study; to aim at sedulously; to devote one's thoughts to; as, to study the welfare of others; to study variety in composition. "For their heart studieth destruction." (Prov. Xxiv. 2)
Origin: OE. Studie, L. Studium, akin to studere to study; possibly akin to Gr. Haste, zeal, to hasten; cf. OF. Estudie, estude, F. Etude. Cf. Etude, Student, Studio, Study, v. I.
1. A setting of the mind or thoughts upon a subject; hence, application of mind to books, arts, or science, or to any subject, for the purpose of acquiring knowledge. "Hammond . . . Spent thirteen hours of the day in study." (Bp. Fell) "Study gives strength to the mind; conversation, grace." (Sir W. Temple)
2. Mental occupation; absorbed or thoughtful attention; meditation; contemplation. "Just men they seemed, and all their study bent To worship God aright, and know his works." (Milton)
3. Any particular branch of learning that is studied; any object of attentive consideration. "The Holy Scriptures, especially the new Testament, are her daily study." (Law) "The proper study of mankind is man." (Pope)
4. A building or apartment devoted to study or to literary work. "His cheery little study."
5. A representation or rendering of any object or scene intended, not for exhibition as an original work of art, but for the information, instruction, or assistance of the maker; as, a study of heads or of hands for a figure picture.
6. A piece for special practice. See Etude.
Source: Websters Dictionary
(01 Mar 1998)
study, crossover A type of clinical trial in which the study subjects receive each treatment in a random order. In this type of study, every patient serves as his or her own control.
(12 Dec 1998)
study, cross-sectional A study done at one time, not over the course of time. A cross-sectional study a disease such as aids might be designed to learn its prevalence and distribution within the population at one point in time. Also known as a synchronic study.
(12 Dec 1998)
study, diachronic See: Study, longitudinal.
(12 Dec 1998)
study, longitudinal A study done over the passage of time. For example, a longitudinal study of children with down syndrome (trisomy 21) might involve the study of 100 children with this condition from birth to 10 years of age. Also called a diachronic study. The opposite of a cross-sectional (synchronic) study.
(12 Dec 1998)
study, preclinical A study to test a drug, procedure or medical treatment in animals. The aim is to collect data in support of safety. Preclinical studies are required before clinical trials can be started.
(12 Dec 1998)
study, synchronic See: Study, cross-sectional.
(12 Dec 1998)
synchronic study <epidemiology> A study in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with longitudinal studies which are followed over a period of time.
Synonym: horizontal study.
(18 Jul 2002)
diachronic study A study done over the course of time. For example, a longitudinal study of children with Down syndrome (trisomy 21) might involve the study of 100 children with this condition from birth to 10 years of age. Also called a longitudinal study. The opposite of a synchronic (cross-sectional) study.
(12 Dec 1998)
double-blind study A study in which neither the experimenter nor any other assessor of the results, including patients, know which group is subject to which procedure, thus helping assure that the biases or expectations of either will not influence the results.
(05 Mar 2000)
epidemiologic study characteristics Types and formulations of studies used in epidemiological and clinical research.
(12 Dec 1998)
twin study A method of detecting genetic causes in human traits and genetic factors in behaviour using sets of twins.
(12 Dec 1998)
foetal doppler study <radiology> Non-stress test (NST), external monitoring for 20 minutes; poor specificity, greater than4 foetal heart accelerations (greater than15 bpm over baseline for 15 seconds) following foetal movement in foetus greater than34 weeks, no heart accelerations in immaturity, sleep, maternal sedation contraction stress test (CST), external monitoring after oxytocin or maternal breast stimulation, greater than 3 uterine contraction in 10 minutes; 50% specificity uterine and umbilical artery waveform, elevated systolic:diastolic ratio = increased vascular resistance foetal aortic flow volume, 185-246 ml/kg/min see also: biophysical profile, intrauterine growth retardation (IUGR)
(12 Dec 1998)
follow-up study Study in which persons exposed to risk or given a designated preventive or therapeutic regimen are observed over a period or at intervals to determine the outcome of the exposure or regimen.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • study
    ÇÏ´Ù;(´ë»çµîÀ»)¾Ï±âÇÏ´Ù
  • nerve
    »·»·½º·¯¿ò
  • nerve-racking
    ½Å°æÀ» °Çµå¸®´Â
  • nerve-wracking
    ½Å°æÀ» °Çµå¸®´Â
  • cranial nerve
    ³ú½Å°æ
  • facial nerve
    ¾È¸é ½Å°æ
  • nerve
    ½Å°æ;Ä¡¼ö;(Åë¼ÓÀûÀ¸·Î)(ÀÌÀÇ)½Å°æ;±Ù¿ø;ÁßÃß;ÈûÁÙ;°Ç;¿ë±â;´ã·Â;±â·Â;Á¤½Å·Â;»·»·½º·¯¿ò;¹«·Ê;¹Î°¨ÇѰ÷(½Å°æ¿¡ °É¸®´Â)¹Ì¹¦ÇÑ Á¡;½Å°æÀÌ»ó(°ú¹Î);¾È´Þ;°Ì;¿ì¿ï;½Å°æ°ú¹ÎÁõ;È÷½ºÅ׸®;ÀÙ¸Æ;³¯°³¸Æ
  • nerve
    ÈûÀ» ÁÖ´Ù;¿ë±â¸¦ ºÏµ¸¿ì´Ù;°Ý·ÁÇÏ´Ù
  • nerve agent
    (±º¿ëÀÇ)½Å°æ°è¿¡ ÀÛ¿ëÇÏ´Â ¹°Áú;½Å°æ°¡½º(µî)
  • nerve block
    ½Å°æÂ÷´Ü(¹ý)(±¹ºÎ ¸¶ÃëÀÇ ÀÏÁ¾)
  • nerve cell
    ½Å°æ¼¼Æ÷
  • nerve center
    ½Å°æÁßÃß;(Á¶Á÷,¿îµ¿µîÀÇ)ÁßÃß(Áß½É)ºÎ;¼ö³úºÎ
  • nerve cord
    (¹«Ã´Ãßµ¿¹°ÀÇ)½Å°æ»è
  • nerve fiber
    ½Å°æ¼¶À¯
  • nerve gas
    ½Å°æ°¡½º(µ¶°¡½ºÀÇ ÀÏÁ¾)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á